Tyrosine

DRUG5 trials

Sponsors

National Institute on Drug Abuse (NIDA), University of Florida, Icahn School of Medicine at Mount Sinai, New York Institute of Technology, Aswan University

Conditions

Amphetamine-Related DisordersFibromyalgiaFocal VitiligoHealthyParkinson's Disease

Early Phase 1

Efficacy of Topical Tyrosine Versus Topical 5-Fluorouracil With Fractional Erbium YAG Laser

RecruitingNCT07742982

Aswan UniversityFocal Vitiligo

Start: 2026-06-01End: 2027-06-10Target: 40Updated: 2026-08-11

Phase 1

The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease

CompletedNCT01676103

New York Institute of TechnologyParkinson's Disease

Start: 2012-09-30End: 2013-11-30Updated: 2014-04-16

Phase 2

Tyrosine for Methamphetamine Dependence - 1

CompletedNCT00000322

National Institute on Drug Abuse (NIDA)Amphetamine-Related Disorders

Start: 1997-04-30End: 2001-12-31Target: 89Updated: 2017-01-12

Unknown Phase

Pharmacotoxicology of Trichloroethylene Metabolites

TerminatedNCT00865514

University of FloridaHealthy

Start: 2011-08-31End: 2012-01-31Updated: 2015-06-03

L-Tyrosine Supplementation in Patients With Fibromyalgia

TerminatedNCT01219049

Icahn School of Medicine at Mount SinaiFibromyalgia

Start: 2010-01-31End: 2011-01-31Updated: 2017-04-11

Related Papers

Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Movement Disorders Clinical Practice2014-10-2315 citations